Completed Mental Health Psychology & Behaviour

Optimising AVATAR therapy for distressing voices: a multi-centre randomised controlled trial

In plain English

AI plain-English summary

People who hear distressing voices will test a digital therapy that lets them build and speak to a 3D avatar of the voice they hear, in a large-scale trial across multiple NHS sites. This matters because around one in four people with psychosis experience persistent voices that standard treatments—medication and talking therapies—often fail to quieten. AVATAR therapy, developed in earlier smaller studies, allows a therapist to help a patient create a computer-generated face and voice that represents their tormentor, then guides them through a conversation where the avatar gradually becomes less powerful and more supportive. The current trial will compare a shorter, simpler version of the therapy (phase 1) against the full two-phase version, to see which works best for which patients. If successful, the research could give the NHS a proven, cost-effective treatment for distressing voices that is easier to roll out than current specialised psychological therapies. The simpler phase 1 approach requires less advanced therapeutic training, meaning it could be delivered more widely and at lower cost. The team also aims to produce enough evidence for NICE to recommend AVATAR therapy as a standard NHS treatment, which would pave the way for adoption in other countries' healthcare systems.

View original technical description
Our long-term vision is that AVATAR therapy is optimised for delivery in clinical settings, with the impact that a novel effective treatment for distressing voices is readily adopted in UK and international clinical settings. As a result of the current study we expect the impact to be: - Software platform tested and optimised for use in NHS settings - Further evidence of effectiveness and the relative cost effectiveness of two therapy levels, including a further elaboration of the participants for whom the simpler phase 1 approach would be sufficient. The advantage of this being that the therapy would be more rapidly disseminated as the more straightforward skills needed for this phase are widely available and at lower cost both in the UK and internationally compared to the specialised psychological therapy skills necessary for phase 2 - Clarity about optimal therapy content and training, with published therapy operational and clinical manuals - Evidence sufficient for a NICE recommendation of AVATAR as a treatment in the NHS. This is a key next step in the wider dissemination of this therapy in the UK and will also be helpful data for similar clinical guideline and policy recommendations in the US and elsewhere

View the original record at the funder ↗

Researchers

Andrew Gumley (EPMC Awardee)Gillian Haddock (EPMC Awardee)Mark Huckvale (EPMC Awardee)Miriam Fornells-Ambrojo (EPMC Awardee)Paul McCrone (EPMC Awardee)Philippa Garety (EPMC Awardee)Richard Emsley (EPMC Awardee)Thomas Craig (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

AVATAR2: Optimising AVATAR therapy for distressing voices: a multi-centre randomised controlled trial
AVATAR therapy in the Real World (AVATAR-RW): A process evaluation, effectiveness and cost-effectiveness study in routine care of AVATAR therapy, a digitally supported therapy for distressing voices.
AVATAR therapy implementation and innovation: Testing delivery of standard AVATAR therapy across settings in sub-Saharan Africa and South Asia alongside UK-based automation
A novel dialogical therapy (Talking With Voices) in comparison to treatment as usual in adults with distressing and persistent auditory hallucinations: A randomised controlled trial to investigate the efficacy of a treatment strategy targeted at trauma-related mechanisms
A feasibility and acceptability study of the Talking With Voices intervention amongst adults with psychosis.

Original classification

Innovations Priority Project

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.